Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial

Overview of attention for article published in Lancet Neurology, April 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news: 4 news outlets
blogs: 2 blogs
twitter: 107 X users

reddit: 1 Redditor
guideline: 2 clinical guideline sources

Readers on

mendeley: 55 Mendeley

So far, Altmetric has seen 5 news stories from 4 outlets.

New Data to Alter Planned ICH Guidelines

Medscape, 30 Oct 2024

ABU DHABI, UAE — In the past 9 months, a surge of new trials related to the management of intracranial hemorrhage (ICH) has led…

Top Studies From ESOC 2024 in Review

Medscape, 19 Jun 2024

This transcript has been edited for clarity. Dear colleagues, I'm Christoph Diener from the University Duisburg-Essen.

No evidence to support tranexamic acid in ICH: Aussie study

Thelimbic, 01 May 2024

Tranexamic acid should not be used routinely in patients with intracerebral haemorrhage, according to results of an Australian-le…

High BMI and Longevity; Infective Endocarditis in Young Whites; Damar Hamlin Update

MSN, 23 Apr 2024

A were causally associated with longevity for people older than 80, according to a Mendelian randomization study.

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 1 additional news stories.